Bridging hepatic necrosis - Etiology and prognosis

Rose D. Spitz, David F. Keren, John K. Boitnott, Willis C. Maddrey

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The probable etiology and outcome of bridging hepatic necrosis found on a liver biopsy performed within three months of the onset of clinical illness was evaluated in 42 consecutive patients with this finding. Eighteen of the patients (43%) had a probable drug etiology for their hepatitis. Ten patients had HBsAG-positive acute hepatitis. Fourteen patients had neither drug-induced disease nor proven HBsAg-positive hepatitis. One patient from the drug-induced group died, but the other 17 had complete clinical recovery. Eight of ten in the hepatitis B antigen-positive group cleared their antigen and had complete clinical recovery. Chronic hepatitis developed in two who remained persistently HBsAg positive. Eight of the patients in the group with unknown etiology recovered, while six developed evidence of active chronic liver disease. This incidence of active chronic liver disease is significantly greater than that found in the drug-induced group (P<0.02). We conclude that drug-induced hepatitis accounts for a significant proportion of patients of acute hepatitis who have bridging hepatic necrosis on liver biopsy. However, in these drug-induced cases the finding of bridging hepatic necrosis does not appear to be associated with an increased risk of development of active chronic liver disease.

Original languageEnglish (US)
Pages (from-to)1076-1078
Number of pages3
JournalThe American Journal of Digestive Diseases
Volume23
Issue number12
DOIs
StatePublished - Dec 1978

Fingerprint

Necrosis
Liver
Hepatitis
Liver Diseases
Chronic Disease
Pharmaceutical Preparations
Hepatitis B Surface Antigens
Hepatitis B Antigens
Chemical and Drug Induced Liver Injury
Biopsy
Chronic Hepatitis
Antigens
Incidence

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Bridging hepatic necrosis - Etiology and prognosis. / Spitz, Rose D.; Keren, David F.; Boitnott, John K.; Maddrey, Willis C.

In: The American Journal of Digestive Diseases, Vol. 23, No. 12, 12.1978, p. 1076-1078.

Research output: Contribution to journalArticle

Spitz, Rose D. ; Keren, David F. ; Boitnott, John K. ; Maddrey, Willis C. / Bridging hepatic necrosis - Etiology and prognosis. In: The American Journal of Digestive Diseases. 1978 ; Vol. 23, No. 12. pp. 1076-1078.
@article{2da9d8d3ca9949c48e5561b36b8d294c,
title = "Bridging hepatic necrosis - Etiology and prognosis",
abstract = "The probable etiology and outcome of bridging hepatic necrosis found on a liver biopsy performed within three months of the onset of clinical illness was evaluated in 42 consecutive patients with this finding. Eighteen of the patients (43{\%}) had a probable drug etiology for their hepatitis. Ten patients had HBsAG-positive acute hepatitis. Fourteen patients had neither drug-induced disease nor proven HBsAg-positive hepatitis. One patient from the drug-induced group died, but the other 17 had complete clinical recovery. Eight of ten in the hepatitis B antigen-positive group cleared their antigen and had complete clinical recovery. Chronic hepatitis developed in two who remained persistently HBsAg positive. Eight of the patients in the group with unknown etiology recovered, while six developed evidence of active chronic liver disease. This incidence of active chronic liver disease is significantly greater than that found in the drug-induced group (P<0.02). We conclude that drug-induced hepatitis accounts for a significant proportion of patients of acute hepatitis who have bridging hepatic necrosis on liver biopsy. However, in these drug-induced cases the finding of bridging hepatic necrosis does not appear to be associated with an increased risk of development of active chronic liver disease.",
author = "Spitz, {Rose D.} and Keren, {David F.} and Boitnott, {John K.} and Maddrey, {Willis C.}",
year = "1978",
month = "12",
doi = "10.1007/BF01072881",
language = "English (US)",
volume = "23",
pages = "1076--1078",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "12",

}

TY - JOUR

T1 - Bridging hepatic necrosis - Etiology and prognosis

AU - Spitz, Rose D.

AU - Keren, David F.

AU - Boitnott, John K.

AU - Maddrey, Willis C.

PY - 1978/12

Y1 - 1978/12

N2 - The probable etiology and outcome of bridging hepatic necrosis found on a liver biopsy performed within three months of the onset of clinical illness was evaluated in 42 consecutive patients with this finding. Eighteen of the patients (43%) had a probable drug etiology for their hepatitis. Ten patients had HBsAG-positive acute hepatitis. Fourteen patients had neither drug-induced disease nor proven HBsAg-positive hepatitis. One patient from the drug-induced group died, but the other 17 had complete clinical recovery. Eight of ten in the hepatitis B antigen-positive group cleared their antigen and had complete clinical recovery. Chronic hepatitis developed in two who remained persistently HBsAg positive. Eight of the patients in the group with unknown etiology recovered, while six developed evidence of active chronic liver disease. This incidence of active chronic liver disease is significantly greater than that found in the drug-induced group (P<0.02). We conclude that drug-induced hepatitis accounts for a significant proportion of patients of acute hepatitis who have bridging hepatic necrosis on liver biopsy. However, in these drug-induced cases the finding of bridging hepatic necrosis does not appear to be associated with an increased risk of development of active chronic liver disease.

AB - The probable etiology and outcome of bridging hepatic necrosis found on a liver biopsy performed within three months of the onset of clinical illness was evaluated in 42 consecutive patients with this finding. Eighteen of the patients (43%) had a probable drug etiology for their hepatitis. Ten patients had HBsAG-positive acute hepatitis. Fourteen patients had neither drug-induced disease nor proven HBsAg-positive hepatitis. One patient from the drug-induced group died, but the other 17 had complete clinical recovery. Eight of ten in the hepatitis B antigen-positive group cleared their antigen and had complete clinical recovery. Chronic hepatitis developed in two who remained persistently HBsAg positive. Eight of the patients in the group with unknown etiology recovered, while six developed evidence of active chronic liver disease. This incidence of active chronic liver disease is significantly greater than that found in the drug-induced group (P<0.02). We conclude that drug-induced hepatitis accounts for a significant proportion of patients of acute hepatitis who have bridging hepatic necrosis on liver biopsy. However, in these drug-induced cases the finding of bridging hepatic necrosis does not appear to be associated with an increased risk of development of active chronic liver disease.

UR - http://www.scopus.com/inward/record.url?scp=0018256870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018256870&partnerID=8YFLogxK

U2 - 10.1007/BF01072881

DO - 10.1007/BF01072881

M3 - Article

C2 - 736015

AN - SCOPUS:0018256870

VL - 23

SP - 1076

EP - 1078

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 12

ER -